For the Inventor, By the Inventor

Enter inventor name

Mountain View, CA, United States of America

Aesop Cho

USPTO Granted Patents = 56 (Patent Applications = 10)

CIPO Patents = 13 (Patent Applications = 2)

EPO Patents = 26 (Patent Applications = 28)

Average Co-Inventor Count = 7.8

ph-index = 25

Forward Citations = 1,708(Granted Patents)

Forward Citations (Not Self Cited) = 1,611(Oct 12, 2025)

Inventors with similar research interests:

Location History:

Foster City, CA (US) (2012 - 2016)
Mountain View, CA (US) (2003 - 2023)

Company Filing History:

Gilead Sciences, Inc.

Gilead Pharmasset LLC

Essential Therapeutics, Inc.

4. 1 out of 200

Daiichi Pharmaceutical Co., Ltd.

Trine Pharmaceuticals, Inc.

where one patent can have more than one assignee

Years Active: 2003-2025

Loading Chart...

Loading Chart...

Loading Chart...

56 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12338233 - PD-1/Pd-L1 inhibitors (2025-06-24),

2. 12269812 - PD-1/PD-L1 inhibitors (2025-04-08),

3. 11555029 - PD-1/PD-L1 inhibitors (2023-01-17),

4. 11352329 - HIV protease inhibitors (2022-06-07),

5. 11318119 - HIV protease inhibitors (2022-05-03),

6. 10988498 - Processes and intermediates for the preparation of 1'-substituted carba-nucleoside analogs (2021-04-27),

7. 10899735 - PD-1/PD-L1 inhibitors (2021-01-26),

8. 10774071 - PD-1/PD-L1 inhibitors (2020-09-15),

9. 10774053 - HIV protease inhibitors (2020-09-15),

10. 10710986 - PD-1/PD-L1 inhibitors (2020-07-14),

11. 10023600 - Processes and intermediates for the preparation of 1'-substituted carba-nucleoside analogs (2018-07-17),

12. 9981955 - Antiviral compounds (2018-05-29),

13. RE46762 - 1'-substituted carba-nucleoside analogs for antiviral treatment (2018-03-26),

14. 9511056 - Antiviral compounds (2016-12-06),

15. 9487544 - Methods for the preparation of diasteromerically pure phosphoramidate prodrugs (2016-11-08),

Title: The Innovator Unveiled: Aesop Cho's Contributions in Medical Science

Introduction: Aesop Cho, a distinguished inventor hailing from Mountain View, CA, has made significant strides in the field of medical innovation. With an impressive portfolio of 54 patents to his name, Cho's groundbreaking work has revolutionized the landscape of cancer and HIV treatment.

Latest Patents: Among his recent patents, Aesop Cho has ventured into pioneering research on PD-1/PD-L1 inhibitors - compounds that show promise in the treatment of cancer. Additionally, his work on HIV protease inhibitors has opened new avenues in combating the HIV virus and managing AIDS symptoms effectively.

Career Highlights: Aesop Cho's professional journey has been enriched by his tenure at esteemed companies such as Gilead Sciences, Inc. and Gilead Pharmasset LLC. Within these organizations, Cho has been instrumental in driving innovation and bringing forth novel solutions to complex medical challenges.

Collaborations: Alongside his accomplished career, Aesop Cho has had the privilege of collaborating with industry experts such as Choung U Kim and William John Watkins. Together, they have formed a dynamic team, fostering creativity and expertise in their pursuit of medical advancements.

Conclusion: In conclusion, Aesop Cho's unwavering dedication to innovation and penchant for cutting-edge research have solidified his position as a trailblazer in the realm of medical science. His patents stand as a testament to his ingenuity and commitment to improving healthcare outcomes for patients worldwide.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…